Cyclophosphamide (CY)/G-CSF Cannot Completely Overcome Imid-Induced Impairment of Peripheral Blood Stem Cell (PBSC) Mobilization (Mob) in Patients With Multiple Myeloma (MM)
Samira Osman(West Virginia University Hospitals), Mehdi Hamadani(Medical College of Wisconsin), Abraham S. Kanate(HonorHealth), Kent Hart(West Virginia University Hospitals), Michael Craig(Edith Cowan University), Jame Abraham(Cleveland Clinic), Laura W. Goff(Vanderbilt University Medical Center), S. C. Remick(West Virginia University Hospitals), Pamela Bunner(West Virginia University), Aaron Cumpston(West Virginia University Hospitals), William Tse(Lurie Children's Hospital), Sonia Leadmon(West Virginia University)
Cited by 0
Related Papers
Hepatobiliary Cancers
|Journal of the National Comprehensive Cancer Network|2009|2.3k
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
|Transplantation and Cellular Therapy|2020|718
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
|Journal of Clinical Oncology|2017|664
Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease
|Journal of Clinical Oncology|2019|441